Heartbeam (BEAT) vs InspireMD (NSPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Heartbeam (BEAT) has outperformed InspireMD (NSPR) over the past year, losing 69.1% versus a loss of 78.8%. Heartbeam is the larger company by market cap ($27.8 million vs $23.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BEAT | NSPR |
|---|---|---|
| Share price | $0.4931 | $0.5001 |
| Market cap | $27.79M | $23.25M |
| 1-day change | -9.16% | -2.70% |
| YTD return | -77.38% | -71.12% |
| 1-year return | -69.15% | -78.76% |
| 5-year return | — | -87.88% |
| EPS (TTM) | $-0.50 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.00 | $2.54 |
| 52-week low | $0.355 | $0.4724 |
| Distance from 52-week high | -87.67% | -80.31% |
| Average volume | 7.32M | 77.47K |
| Shares outstanding | 56.35M | 46.49M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BEAT vs NSPR FAQ
Which is bigger, Heartbeam or InspireMD?
Heartbeam (BEAT) is larger, with a market capitalization of $27.79M compared with $23.25M for InspireMD (NSPR).
Which stock has performed better over the past year, BEAT or NSPR?
BEAT returned -69.15% over the past 12 months, compared with -78.76% for NSPR (price return, excluding dividends). Past performance does not predict future results.
Are Heartbeam and InspireMD in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.